glutathione for parkinson's Central nervous system uptake of intranasal in disease low glutathione levels parkinson's disease

C.Zia Ul Haq KatshuM.LiddleP

Clinical research has indicated that FOXO4-DRI has shown promise in the following areas: Targets senescent cells FOXO4-DRI is a synthetic peptide designed to target senescent cells, which are damaged cells that stop dividing but resist apoptosis (programmed cell death)

doi:10.1002/(SICI)1097-0177(199901)214:1 3.0.CO;2-X

In addition, a recent study assessed the influence of intravenous high-dose NAC (29 g, IV within 2 days) combined with low-dose nitroglycerin (7.2 mg, IV within 2 days) on infarct size in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention (PCI)